Clinical Research Directory
Browse clinical research sites, groups, and studies.
U-LABA/ICS Effects on Exercise Performance, Vilanterol
Sponsor: Morten Hostrup, PhD
Summary
The purpose of the project is to investigate exercise performance in humans following bronchodilation induced by acute inhalation of beta2-agonist vilanterol + fluticasone furoate
Official title: Physiological Response to U-LABA/ICS With Emphasis on Exercise Performance, Vilanterol
Key Details
Gender
All
Age Range
18 Years - 39 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2023-10-03
Completion Date
2026-12-01
Last Updated
2025-04-10
Healthy Volunteers
Yes
Conditions
Interventions
Vilanterol and Fluticasone Furoate (low dose)
Participants are administered 25 µg of vilanterol + fluticasone furoate
Vilanterol and Fluticasone Furoate (high dose)
Participants are administered 100 µg of vilanterol + fluticasone furoate
Placebo
Participants are administered placebo
Locations (1)
August Krogh Building
Copenhagen, DK, Denmark